Please try another search
For the three months ended 31 March 2022, Woojung BIO Inc revenues increased 46% to W13.23B. Net loss totaled W913.9M vs. income of W357.5M. Revenues reflect infection control segment increase of 63% to W11.46B, South Korea (Country) segment increase of 47% to W12.92B, Asia (Region)-South Korea (Country) segment increase of 21% to W315.2M. Net loss reflects Interest Expense - Gross increase from W187.7M to W631.1M (expense).
Period Ending: | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Revenue | 4844.82 | 8105.74 | 10654.83 | 9935.42 |
Gross Profit | 442.97 | 1224.59 | 1732.96 | 1865.17 |
Operating Income | -2135.22 | -1471.93 | -620.27 | -297.09 |
Net Income | -2744.65 | -3837.82 | 3307.06 | -854.95 |
Period Ending: | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Assets | 96726.79 | 91936.03 | 94993.77 | 99836.75 |
Total Liabilities | 66997.64 | 57364.95 | 65275.43 | 60878.6 |
Total Equity | 29729.15 | 34571.08 | 29718.34 | 38958.15 |
Period Ending: | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -3068.51 | -2538.26 | 5107.93 | -3983.26 |
Cash From Investing Activities | 141.55 | 709.55 | -2776.26 | 119.82 |
Cash From Financing Activities | -249.28 | 320.08 | -1978.8 | 247.91 |
Net Change in Cash | -3204.55 | -1502.95 | 344.25 | -3608.45 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review